Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. - Wikidata - wikimedia - TriplyDB

Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

http://www.wikidata.org/entity/Q34916417

about

A risk prediction model for smoking experimentation in Mexican American youth.Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.Outcomes of screening endometrial cancer patients for Lynch syndrome by patient-administered checklist Evaluation of prediction models for decision-making: beyond calibration and discrimination The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms Women's Awareness and Attitude Toward Breast Self-Examination in Dezful City, Iran, 2013.Optimal cutoffs of obesity measures in relation to cancer risk in postmenopausal women in the Women's Health Initiative Study An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.Breast cancer risk in older women: results from the NIH-AARP Diet and Health Study.Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy.Does alcohol consumption modify the risk of endometrial cancer? A dose-response meta-analysis of prospective studies.A Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data From the Nurses' Health Study.Twenty-five years of breast cancer risk models and their applications Symposium on advances in endometrial cancer epidemiology and biology.Brain Biomarkers of Vulnerability and Progression to Psychosis Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.Epidemiology of ovarian cancer: a review.Evaluating disease prediction models using a cohort whose covariate distribution differs from that of the target population.Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.A GPS-Based Methodology to Analyze Environment-Health Associations at the Trip Level: Case-Crossover Analyses of Built Environments and Walking.An Individualized Risk Calculator for Research in Prodromal Psychosis.Short-term and long-term clinical outcomes of uncommon types of invasive breast cancers.Use of Underarm Cosmetic Products in Relation to Risk of Breast Cancer: A Case-Control Study.Associations of parity-related reproductive histories with ER± and HER2± receptor-specific breast cancer aetiology.An epidemiological model for prediction of endometrial cancer risk in Europe.A prospective study of cigarette smoking and basal cell carcinoma.Endometrial cancer evolution: new molecular-biologic types and hormonal-metabolic shifts.Epidemiologic paradigms for progress in ovarian cancer research.Semiparametric analysis of complex polygenic gene-environment interactions in case-control studies.A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort.Do breast cancer risk factors differ among those who do and do not undertake mammography screening?The bidirectional association among female hormone-related cancers: breast, ovary, and uterine corpus.Risk factors for breast cancer in a cohort of mammographic screening program: a nested case-control study within the FRiCaM study.ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway.Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials.A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening

P2860

Q30588859-B5FA13D4-C121-4E40-807D-A0E8F1586996 Q31153145-BA974372-EF91-493A-8522-2E8515F182A1 Q34008620-D23498E5-5FB7-4DDD-83CF-D91DFC3AEA38 Q34916393-752A22CA-711F-4C1B-B22C-B5DD44FA8860 Q35030287-A418FCBD-7D99-42E6-8777-7EA97326C1AF Q35124304-C6D99077-941C-45A6-92A5-C86BD78EDAE7 Q35188724-DAB75ED5-8958-405B-8E23-EAB5E52EF8B3 Q35274864-2AFD8080-777D-467A-B09C-2E94366F8CB7 Q35592002-866BC80E-07DE-4DBB-B927-F0BCD4B6A608 Q35855168-2E2C0DCB-A6D7-442E-A17A-7F3BF6BB5C35 Q36224294-21A09422-A522-4956-92CF-E17B1ED975D6 Q36245897-042A374B-96E2-4DC7-A1A2-055C752AEC65 Q36294980-00BE7692-5618-414C-A670-1016C0BE9B40 Q37011786-B4B6AB1D-D34D-4110-9DBA-2D220D93D06E Q37124940-0072A541-937B-4E33-8FC5-C6613F6AFBEE Q37234793-274DC601-4BF6-4CE8-BD8F-867326F7074D Q37720438-D5E2997A-4821-4023-B8E8-8DB9E0422664 Q38622535-C154FA30-8C78-4FAF-83D3-5C28875F8BF5 Q38788210-590266F8-EFB3-4414-9C24-7E829232306A Q39116052-E0E39EDB-AD33-4F0C-BEC2-5166FAD30741 Q39326953-0CE5D9B9-6F31-4359-8AEF-E7AC8E4F9EAC Q39360191-1D0B1C09-0420-4790-A9E7-EC17EB1C5D07 Q39642063-BD3443AB-0400-4205-8419-13EBA4313C30 Q40107400-0EEFFE81-8109-4E4B-8790-3FBE70178A72 Q40153828-9CD152F0-B155-4691-BDE8-E4807FECDD38 Q40487038-AE4BDF4B-91B9-4BC0-B0E6-825D9AD651C2 Q40946063-D09E07C5-A7A8-4961-B53F-5405127E42DF Q42465869-C1C609D1-C15D-486F-B4B3-A47AF9BB13FE Q47424270-B1C6B2BB-14A7-45DF-8B90-959D9C183CD3 Q47583338-8997A639-D5FF-4ED1-88A7-29C79F399097 Q49726138-CA1FF474-C760-492D-9510-F5981A9A52A0 Q50597400-F6A7242C-EB03-443F-97A3-90E7A2D916B4 Q51228168-F0BAE5B7-0764-4F9D-9C2D-A27BD33A46E7 Q52586345-75C11D40-8BC8-4358-840F-699E0FA5386D Q52588842-4703C06D-78EF-4F62-B2CC-FC2CA072142D Q53224664-0E817B51-8424-4715-BFCE-62B65CDE58E5 Q53618240-81BF16A4-F6AF-4C03-A4EF-2BEB45F70695 Q57586180-063ED086-ED71-42BF-8145-A41947FDBF10

P2860

Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

http://www.wikidata.org/entity/Q34916417

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Risk prediction for breast, en ...... pulation-based cohort studies.

@ast

Risk prediction for breast, en ...... pulation-based cohort studies.

@en

Risk prediction for breast, en ...... pulation-based cohort studies.

@nl

type

label

Risk prediction for breast, en ...... pulation-based cohort studies.

@ast

Risk prediction for breast, en ...... pulation-based cohort studies.

@en

Risk prediction for breast, en ...... pulation-based cohort studies.

@nl

prefLabel

Risk prediction for breast, en ...... pulation-based cohort studies.

@ast

Risk prediction for breast, en ...... pulation-based cohort studies.

@en

Risk prediction for breast, en ...... pulation-based cohort studies.

@nl

P1433

Q34916417-D8218FA2-76CC-48A7-A12D-8FA3EA786768

P1476

Q34916417-20CECA2E-970B-48BD-9069-98A75EF18D0C

P2093

Q34916417-011BBADB-1695-4778-BB1A-038332AD3D84

Q34916417-0A590DFE-7AF4-4E5E-9A3B-C3B89C276F86

Q34916417-1D9A00AA-7579-41AF-86BC-1EE51D5C8E42

Q34916417-2A203DD3-14C0-477A-82EF-0E2DCB0F3F40

Q34916417-2E15FF84-AF55-4C42-B97E-694F0ED1611B

Q34916417-76326E53-A529-405E-A819-F60E99AC850B

Q34916417-BC169D4C-DABA-4EF4-A3C0-4D16C6A9A72A

Q34916417-C50C9947-C782-4CEF-9957-88318C5B45E2

Q34916417-C8616CDE-31C2-45F3-A176-A8F466B0CA2A

P2860

Q34916417-0A54A6E7-C376-4F51-B80A-3F38B8622DFC

Q34916417-52DC53B9-830F-40A4-833E-B18540E9254D

Q34916417-55B4F897-AB21-4CE0-B455-28F03B6B46C7

Q34916417-5B80CAD1-5120-46ED-927D-2734862A3E53

Q34916417-5DB36A41-8422-456E-BA33-6461B7BA6C78

Q34916417-87535673-E177-4D7F-90B0-71DCB2FBE4CE

Q34916417-90ADD785-AC0E-443E-AB66-7643B040F51B

Q34916417-9DE3222C-37E6-4884-9CA8-138506A3DC33

Q34916417-B263AD2E-1E77-4773-8555-4F76FA2C8C79

Q34916417-C4EC2EEE-3292-4A8D-8E52-2148803FF628

P304

Q34916417-48843295-F0A6-4DF5-8C28-98698C9FED40

P31

Q34916417-3B01ECB4-FBF5-4126-ADFE-A0EB05FA1150

P356

Q34916417-AB831883-1445-4841-B99A-2CEA46514751

P407

Q34916417-BD542F21-F9EC-4A7E-85EF-005F78052CAB

P433

Q34916417-9E104DA2-67D2-44A0-9151-F5C42545D113

P478

Q34916417-58EAA26A-0695-4ECB-BB38-6C8557A97E2D

P50

Q34916417-788B6CED-5B2A-45B9-B0AE-16B2DD8CB7C4

Q34916417-A2EDF625-25E1-488F-827D-12A92946A5EF

P577

Q34916417-B5418FCA-E4EA-4DB1-A087-006F4022F93C

P5875

Q34916417-DBD41266-4B19-48CB-A431-EB336E7CCEFC

P698

Q34916417-46B59BC2-6277-4F52-8FA5-39E92A5F96A5

P921

Q34916417-E1C9BF9B-A106-404E-8817-C8864F9AE552

P932

Q34916417-6709960A-3171-4125-97E1-ED12D8C7C99E

P356

JOURNAL.PMED.1001492

P1433

P1476

Risk prediction for breast, en ...... pulation-based cohort studies.

@en

P2093

Aimée R Kreimer

http://www.w3.org/2001/XMLSchema#string

Albert Hollenbeck

http://www.w3.org/2001/XMLSchema#string

Bernard Rosner

http://www.w3.org/2001/XMLSchema#string

David Pee

http://www.w3.org/2001/XMLSchema#string

James V Lacey

http://www.w3.org/2001/XMLSchema#string

Mitchell H Gail

http://www.w3.org/2001/XMLSchema#string

Robert T Greenlee

http://www.w3.org/2001/XMLSchema#string

Ruth M Pfeiffer

http://www.w3.org/2001/XMLSchema#string

Saundra S Buys

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Prevalence and trends in obesity among US adults, 1999-2008

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.

Risk factor modification and projections of absolute breast cancer risk

On criteria for evaluating models of absolute risk.

The Nurses' Health Study: lifestyle and health among women.

Mammographic density, breast cancer risk and risk prediction.

P304

e1001492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.1001492

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Patricia Hartge

P577

2013-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255736745

http://www.w3.org/2001/XMLSchema#string

P698

23935463

http://www.w3.org/2001/XMLSchema#string

P921

P932

3728034

http://www.w3.org/2001/XMLSchema#string